Skip to content

Aflac AFL Cancer — Effect of changes in discount rate assumptions

Other product segments

Medical and other health
-$1.4B-238%
Critical care
-$360M+7.5%
Life insurance
-$345M-321%
Accident
-$148M+7.5%
Hospital indemnity
-$75M+12.8%
Disability
-$62M+13.9%
Other
-$21M-262%
Dental/vision
-$9M+18.2%

Similar metrics at other companies

General Electric logo
GELong-term care — Effect of changes in discount rate assumptions
$175M-0.6%
Ameriprise Financial logo
AMPLong Term Care Insurance — Effect of changes in discount rate assumptions
-$4M+20.0%
Globe Life logo
GLHealth — Effect of changes in discount rate assumptions
-$212.3M-9.3%
MetLife logo
METAccident & health insurance — Effect of changes in discount rate assumptions
-$3.2B-58.5%
Equitable Holdings logo
EQHHealth — Effect of changes in discount rate assumptions
$1M0.0%
KKR & Co. logo
KKROther — Effect of Changes in Discount Rate Assumptions
-$139.84M-22.1%

Other financials

Income statement

See full
Revenue$4.3B+27.9%
Net income$1.0B+3,414%
EPS (diluted)$1.98+3,860%

Balance sheet

See full
Cash & equivalents$5.7B+8.1%
Total debt$8.0B+1.8%
Total equity$30.0B+13.8%
Total assets$116.28B-3.3%

Cash flow

See full
Operating cash flow$968.0M+64.3%

Valuation

See full
Market cap$60.18B+7.8%
Enterprise value$62.52B+6.9%
P/E13×-2.6×
P/S3.3×0.0×

Profitability

See full
Net margin25.6%+4.3pp

Returns & leverage

See full
Return on equity16.5%+2.1pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by Aflac in its filing.

Tagged under the XBRL concept us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax.

The official record: Aflac’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aflac's cancer — effect of changes in discount rate assumptions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aflac's cancer — effect of changes in discount rate assumptions?
Aflac (AFL) reported cancer — effect of changes in discount rate assumptions of -$1.25B in Q1 2026.
How has Aflac's cancer — effect of changes in discount rate assumptions changed year-over-year?
Aflac's cancer — effect of changes in discount rate assumptions decreased by 363.7% year-over-year, from -$270M to -$1.25B.
What is the long-term trend for Aflac's cancer — effect of changes in discount rate assumptions?
Over 2 years (2023 to 2025), Aflac's cancer — effect of changes in discount rate assumptions has grown at a -30.1% compound annual growth rate (CAGR), from $5B to -$2.44B.
What does cancer — effect of changes in discount rate assumptions mean?
The financial impact resulting from changes in the discount rates used to calculate the present value of future policy benefits for the cancer segment. This reflects the sensitivity of long-term liabilities to interest rate environments.